Global Retirement Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-47
| Closed | -$4.12K | – | 3745 |
|
2024
Q3 | $4.12K | Hold |
47
| – | – | ﹤0.01% | 2651 |
|
2024
Q2 | $3.88K | Hold |
47
| – | – | ﹤0.01% | 2718 |
|
2024
Q1 | $3.78K | Hold |
47
| – | – | ﹤0.01% | 2514 |
|
2023
Q4 | $3.59K | Hold |
47
| – | – | ﹤0.01% | 2456 |
|
2023
Q3 | $3.33K | Hold |
47
| – | – | ﹤0.01% | 2342 |
|
2023
Q2 | $3.55K | Hold |
47
| – | – | ﹤0.01% | 2333 |
|
2023
Q1 | $3.62K | Hold |
47
| – | – | ﹤0.01% | 2282 |
|
2022
Q4 | $3.69K | Hold |
47
| – | – | ﹤0.01% | 2124 |
|
2022
Q3 | $4K | Hold |
47
| – | – | ﹤0.01% | 2021 |
|
2022
Q2 | $4K | Hold |
47
| – | – | ﹤0.01% | 1981 |
|
2022
Q1 | $3K | Buy |
+47
| New | +$3K | ﹤0.01% | 2082 |
|
2021
Q4 | – | Sell |
-47
| Closed | -$4K | – | 1363 |
|
2021
Q3 | $4K | Hold |
47
| – | – | ﹤0.01% | 1699 |
|
2021
Q2 | $4K | Hold |
47
| – | – | ﹤0.01% | 1631 |
|
2021
Q1 | $4K | Hold |
47
| – | – | ﹤0.01% | 1534 |
|
2020
Q4 | $3K | Hold |
47
| – | – | ﹤0.01% | 1545 |
|
2020
Q3 | $3K | Hold |
47
| – | – | ﹤0.01% | 1436 |
|
2020
Q2 | $3K | Hold |
47
| – | – | ﹤0.01% | 1402 |
|
2020
Q1 | $3K | Hold |
47
| – | – | ﹤0.01% | 1354 |
|
2019
Q4 | $3K | Hold |
47
| – | – | ﹤0.01% | 1428 |
|
2019
Q3 | $3K | Hold |
47
| – | – | ﹤0.01% | 1404 |
|
2019
Q2 | $3K | Sell |
47
-126
| -73% | -$8.04K | ﹤0.01% | 1390 |
|
2019
Q1 | $11K | Hold |
173
| – | – | ﹤0.01% | 1034 |
|
2018
Q4 | $11K | Hold |
173
| – | – | ﹤0.01% | 947 |
|
2018
Q3 | $13K | Hold |
173
| – | – | ﹤0.01% | 961 |
|
2018
Q2 | $12K | Hold |
173
| – | – | ﹤0.01% | 956 |
|
2018
Q1 | $11K | Hold |
173
| – | – | ﹤0.01% | 944 |
|
2017
Q4 | $11K | Buy |
173
+9
| +5% | +$572 | ﹤0.01% | 880 |
|
2017
Q3 | $11K | Buy |
164
+1
| +0.6% | +$67 | ﹤0.01% | 803 |
|
2017
Q2 | $10K | Hold |
163
| – | – | ﹤0.01% | 790 |
|
2017
Q1 | $10K | Hold |
163
| – | – | 0.01% | 749 |
|
2016
Q4 | $9K | Buy |
+163
| New | +$9K | 0.01% | 722 |
|